Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,009,847
+$260,879 QoQ
Shares Held
50,449
+605.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#2,342
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ellevest, Inc. holds $19,452,346 across 14 Drug Manufacturers - General names. JNJ ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,180 | $3,814,187 | |
| 2 | MRK |
Merck & Co., Inc.
|
23,926 | $3,074,491 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
50,449 | $2,009,847 | |
| 4 | NVS |
Novartis AG
|
12,495 | $1,958,216 | |
| 5 | AZN |
Astrazeneca PLC
|
6,725 | $1,275,194 | |
| 6 | PFE |
Pfizer Inc
|
45,568 | $1,097,277 | |
| 7 | AMGN |
Amgen Inc
|
2,956 | $1,070,426 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,309 | $1,049,759 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,009,847 | 50,449 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,748,968 | 7,155 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,435,819 | 6,938 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,463,705 | 7,894 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $211,558 | 1,385 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $296,024 | 1,785 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $271,162 | 1,875 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $312,289 | 1,927 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $227,132 | 1,554 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $259,431 | 1,640 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $210,658 | 1,344 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $246,552 | 1,583 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $206,237 | 1,246 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $148,025 | 955 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $156,687 | 887 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $142,286 | 871 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $154,078 | 868 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $153,481 | 866 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $157,726 | 922 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $149,549 | 926 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $177,095 | 1,075 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $158,104 | 962 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $229,932 | 1,461 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $575,867 | 3,868 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $175,084 | 1,245 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $155,651 | 1,187 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||